SARS-CoV-2 Antigen Rapid Qualitative Test Type B

Hepatitis C is a liver disease caused by the hepatitis C virus (HCV): the virus can cause both acute and chronic hepatitis, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness. Hepatitis C is a major cause of liver cancer.

SAA Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Serum amyloid A (SAA) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of inflammation diseases.

D-Dimer Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the D-Dimer concentration in human sodium citrate anticoagulant-contained plasma (1:9) and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

Myo Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the myoglobin (Myo) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood, mainly used for auxiliary diagnosis of cardiac diseases.

TheToxoplasma IgG/IgM Rapid Test is an in vitro immunoassay for the in vitro qualitative determination of IgG and IgM class antibodies toToxoplasma gondii in human serum.IgG results with this assay are used to indicate past or recent infection withToxoplasma gondii. IgM results obtained with this assay are used as an aid in the diagnosis of acute or recentToxoplasma gondii infections. Toxoplasma IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy. -Fluorescent immunoassay -Toxoplasma gondii infection -For in vitro diagnostic use only. For professional use only.

The Dengue NS1 Antigen Rapid Test is a lateral flow immunoassay for the qualitative detection of Dengue virus NS1 antigen in human serum, plasma or whole blood. It is intended to be used by professionals as a screening test and provides a preliminary test result to aid in the diagnosis of infection with the dengue virus. For professional in vitro diagnostic use only.

The Biotime S100-β Rapid Quantitative Test is intended to quantify the concentration of S100-β in human serum, plasma, and whole blood on the Biotime FIA Analyzer by fluorescent immunoassay. The test is used as an aid in the detection of neurological injury.